Concomitant and alternating radiation therapy (RT) and chemotherapy (CT) for inoperable, M0, non-small cell lung cancers (NSCLC): a consensus report
dc.contributor.author | Mirimanoff, R. O. | en_US |
dc.contributor.author | Rubin, P. | en_US |
dc.contributor.author | Cox, J. D. | en_US |
dc.contributor.author | Gandara, D. | en_US |
dc.contributor.author | Grunenwald, D. | en_US |
dc.contributor.author | Hazuka, M. | en_US |
dc.contributor.author | Jassem, J. | en_US |
dc.contributor.author | Komaki, R. | en_US |
dc.contributor.author | Mattson, K. | en_US |
dc.contributor.author | McDonald, S. | en_US |
dc.date.accessioned | 2006-04-10T17:49:08Z | |
dc.date.available | 2006-04-10T17:49:08Z | |
dc.date.issued | 1994-11 | en_US |
dc.identifier.citation | Mirimanoff, R. O., Rubin, P., Cox, J. D., Gandara, D., Grunenwald, D., Hazuka, M., Jassem, J., Komaki, R., Mattson, K., McDonald, S. (1994/11)."Concomitant and alternating radiation therapy (RT) and chemotherapy (CT) for inoperable, M0, non-small cell lung cancers (NSCLC): a consensus report." Lung Cancer 11(Supplement 3): S5-S8. <http://hdl.handle.net/2027.42/31248> | en_US |
dc.identifier.uri | http://www.sciencedirect.com/science/article/B6T9C-4C302HS-68/2/91c80916cfc3d3402431bca8cb97ad0b | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/31248 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=7704513&dopt=citation | en_US |
dc.format.extent | 273033 bytes | |
dc.format.extent | 3118 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.language.iso | en_US | |
dc.publisher | Elsevier | en_US |
dc.title | Concomitant and alternating radiation therapy (RT) and chemotherapy (CT) for inoperable, M0, non-small cell lung cancers (NSCLC): a consensus report | en_US |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | en_US |
dc.subject.hlbsecondlevel | Public Health | en_US |
dc.subject.hlbsecondlevel | Otolaryngology | en_US |
dc.subject.hlbsecondlevel | Ophthalmology | en_US |
dc.subject.hlbsecondlevel | Oncology and Hematology | en_US |
dc.subject.hlbsecondlevel | Obstetrics and Gynecology | en_US |
dc.subject.hlbsecondlevel | Neurosciences | en_US |
dc.subject.hlbsecondlevel | Internal Medicine and Specialties | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | University of Michigan, Ann Arbor, MI, USA | en_US |
dc.contributor.affiliationother | Centre Hospitalier Universitaire Vaudois, CHUV, Lausanne, Switzerland | en_US |
dc.contributor.affiliationother | Cancer Center, University of Rochester, Rochester NY, USA | en_US |
dc.contributor.affiliationother | University of Texas M.D. Anderson Cancer Center, Houston, TX, USA | en_US |
dc.contributor.affiliationother | University of California Davis Cancer Center, Sacramento, CA, USA | en_US |
dc.contributor.affiliationother | C.M.C., Porte de Choisy, Paris, France | en_US |
dc.contributor.affiliationother | Medical Academy, Gdansk, Poland | en_US |
dc.contributor.affiliationother | University of Texas M.D. Anderson Cancer Center, Houston, TX, USA | en_US |
dc.contributor.affiliationother | University Hospital, Helsinki, Finland | en_US |
dc.contributor.affiliationother | Cancer Center, University of Rochester, Rochester NY, USA | en_US |
dc.identifier.pmid | 7704513 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/31248/1/0000154.pdf | en_US |
dc.identifier.doi | http://dx.doi.org/10.1016/0169-5002(94)91857-0 | en_US |
dc.identifier.source | Lung Cancer | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.